[go: up one dir, main page]

DD115659A5 - - Google Patents

Info

Publication number
DD115659A5
DD115659A5 DD182648A DD18264874A DD115659A5 DD 115659 A5 DD115659 A5 DD 115659A5 DD 182648 A DD182648 A DD 182648A DD 18264874 A DD18264874 A DD 18264874A DD 115659 A5 DD115659 A5 DD 115659A5
Authority
DD
German Democratic Republic
Application number
DD182648A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed filed Critical
Publication of DD115659A5 publication Critical patent/DD115659A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
DD182648A 1973-11-30 1974-11-28 DD115659A5 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (1)

Publication Number Publication Date
DD115659A5 true DD115659A5 (es) 1975-10-12

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
DD182648A DD115659A5 (es) 1973-11-30 1974-11-28

Country Status (14)

Country Link
US (1) US4045574A (es)
JP (1) JPS5084561A (es)
AT (1) AT347611B (es)
CA (1) CA1030522A (es)
CH (1) CH618183A5 (es)
DD (1) DD115659A5 (es)
DK (1) DK134348C (es)
ES (1) ES432106A1 (es)
FR (1) FR2253512B1 (es)
GB (1) GB1494097A (es)
IE (1) IE40423B1 (es)
IL (1) IL46153A (es)
NL (1) NL7415577A (es)
SE (1) SE408426B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
MXPA05001857A (es) * 2002-08-16 2005-06-03 Upjohn Co Intermedios esteroideos de 5-androsten-38-ol y procedimientos para su preparacion.
WO2014169831A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
MX362543B (es) 2013-04-17 2019-01-24 Sage Therapeutics Inc Esteroides c21-n-pirazolilo 19-nor c3,3- disustituidos y metodos de uso de los mismos.
RU2019126333A (ru) 2013-04-17 2019-10-08 Сейдж Терапьютикс, Инк. 19-нор нейроактивные стероиды и способы их применения
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
SI3021852T1 (sl) 2013-07-19 2021-07-30 Sage Therapeutics, Inc. Nevroaktivni steroidi, sestavki in uporabe le-teh
CN105579043B (zh) 2013-08-23 2021-09-14 萨奇治疗股份有限公司 神经活性类固醇、组合物和其用途
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
RS60642B1 (sr) 2014-10-16 2020-09-30 Sage Therapeutics Inc Kompozicije i postupci za lečenje poremećaja cns-a
TW202426002A (zh) 2014-10-16 2024-07-01 美商賽吉醫療公司 用於治療中樞神經系統(cns)病症之組合物及方法
EP3719029A1 (en) 2014-11-27 2020-10-07 Sage Therapeutics, Inc. Compositions for inducing sedation
DK3250210T3 (da) 2015-01-26 2021-03-08 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
ES2935476T3 (es) 2015-02-20 2023-03-07 Sage Therapeutics Inc Esteroides neuroactivos, composiciones y usos de los mismos
CN116162121A (zh) 2016-07-11 2023-05-26 萨奇治疗股份有限公司 C17、c20和c21取代的神经活性类固醇及其使用方法
EP3481844B1 (en) 2016-07-11 2024-04-17 Sage Therapeutics, Inc. C7, c12, and c16 substituted neuroactive steroids and their methods of use
MA51316A (fr) * 2017-12-22 2020-10-28 Sage Therapeutics Inc Compositions et méthodes permettant de traiter les troubles du snc
MX2021006618A (es) 2018-12-05 2021-09-23 Sage Therapeutics Inc Esteroides neuroactivos y sus metodos de uso.
BR112021013393A2 (pt) 2019-01-08 2021-09-14 Chengdu Kanghong Pharmaceutical Co, Ltd. Composto de esteroide e uso do mesmo e método de preparação para o mesmo
PH12021553005A1 (en) 2019-05-31 2023-08-14 Sage Therapeutics Inc Neuroactive steroids and compositions thereof
MX2021015848A (es) * 2019-06-27 2022-04-18 Sage Therapeutics Inc Composiciones y métodos para el tratamiento de trastornos del snc.
TWI896548B (zh) * 2019-06-27 2025-09-11 美商賽吉醫療公司 用於治療cns病症之組合物及方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
ES432106A1 (es) 1976-11-01
IE40423L (en) 1975-05-30
CH618183A5 (es) 1980-07-15
GB1494097A (en) 1977-12-07
AT347611B (de) 1979-01-10
SE408426B (sv) 1979-06-11
SE7414960L (es) 1975-06-02
NL7415577A (nl) 1975-06-03
IL46153A0 (en) 1975-02-10
DK134348C (da) 1977-03-21
FR2253512B1 (es) 1978-02-03
DK134348B (da) 1976-10-25
FR2253512A1 (es) 1975-07-04
IE40423B1 (en) 1979-05-23
CA1030522A (en) 1978-05-02
DK604174A (es) 1975-07-28
ATA950774A (de) 1978-05-15
US4045574A (en) 1977-08-30
AU7586774A (en) 1976-06-03
JPS5084561A (es) 1975-07-08
IL46153A (en) 1979-01-31

Similar Documents

Publication Publication Date Title
AU476761B2 (es)
AR201235Q (es)
AR201231Q (es)
AU474511B2 (es)
FR2253512B1 (es)
AR201229Q (es)
AR199451A1 (es)
AU477823B2 (es)
AR200256A1 (es)
AR195948A1 (es)
AR195311A1 (es)
AR196382A1 (es)
AR193950A1 (es)
AR197627A1 (es)
AU476873B1 (es)
AR201432A1 (es)
AR200885A1 (es)
AR196212Q (es)
AR196123Q (es)
CH560390A5 (es)
AU479521A (es)
CH562578A5 (es)
CH444574A4 (es)
CH1347073A4 (es)
BG25817A1 (es)